BiotechTube
For-Robin

For-Robin

San Diego, United States· Est.
for-robin.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

For-Robin is a University at Buffalo (UB) spinoff biotech advancing an antibody therapeutic, hJAA-F11, designed to prevent cancer metastasis, particularly in lung and breast cancers. Currently in late preclinical development, the company is preparing for clinical imaging trials slated for 2025-2026 with support from NCI NExT partners. The company is privately funded, having secured at least $2 million in grants, and is driven by a deeply personal mission inspired by the founder's sister.

Oncology

Technology Platform

Proprietary humanized antibody (hJAA-F11) targeting the Thomsen-Friedenreich (TF) antigen to block cancer cell adhesion and prevent metastasis.

Opportunities

The lead antibody, hJAA-F11, targets metastasis—the cause of most cancer deaths—representing a massive unmet need across multiple solid tumors.
Initial development as a diagnostic imaging agent provides a faster, de-risked pathway to clinical validation and potential near-term partnerships, building value for the larger therapeutic program.

Risk Factors

The company faces high translational risk as a single-asset, preclinical biotech, with no guarantee that promising lab results will succeed in human trials.
Financial sustainability depends on securing additional funding beyond grants to advance into costly clinical studies, and operational scaling from an academic project to a clinical-stage company presents a key challenge.

Competitive Landscape

The field of metastasis inhibition is crowded with approaches targeting various pathways (e.g., integrins, chemokines). For-Robin's focus on the TF antigen is a differentiated angle, but it competes with larger, well-funded oncology companies. In the cancer imaging space, it faces competition from established radiopharmaceutical and diagnostic companies.

More companies in Biologics / Biosimilars →More companies in United States →